Share on LinkedInTweet about this on TwitterPin on PinterestShare on FacebookShare on Google+

The combinatorial, multi-gene GeneSight test has been found to better predict antidepressant treatment outcomes for patients with depression, and their use of health care resources, than any of the individual genes that comprise the test, according to a peer-reviewed analysis by investigators from the Mayo Clinic and Assurex Health, and published online by The Pharmacogenomics Journal. …read more

Source:: http://www.news-medical.net/news/20150305/GeneSight-test-better-predicts-antidepressant-outcomes-for-patients-with-depression.aspx

      

Share on LinkedInTweet about this on TwitterPin on PinterestShare on FacebookShare on Google+